Stay updated on GLPG1690 in IPF: ISABELA2 Clinical Trial
Sign up to get notified when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.

Latest updates to the GLPG1690 in IPF: ISABELA2 Clinical Trial page
- Check3 days agoChange DetectedRecruitment status on the study page was updated to No longer looking for participants. The page also gained new guidance links (How to Read a Study Record, Common Questions, How to Join a Study) and a label change for Intervention/Treatment, along with the site revision label updated to v3.6.0.SummaryDifference0.2%

- Check10 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page rendering.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe sponsor name on the study record was updated from Galapagos NV to Lakefront Biotherapeutics NV, reflecting a change in the organization responsible for the trial. This affects the credited sponsor and the primary point of contact for study-related inquiries and regulatory documents.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous v3.5.3 revision tag. This indicates a page version update rather than a substantive update to study details.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s footer shows an updated system/software release identifier, moving from “Revision: v3.5.2” to “Revision: v3.5.3”.SummaryDifference0.0%

- Check60 days agoChange DetectedIdiopathic Pulmonary Fibrosis is now listed on the page and a new Resources section for the Genetic and Rare Diseases Information Center has been added. The revision notes indicate an update to v3.5.2, replacing the prior v3.5.0.SummaryDifference0.1%

Stay in the know with updates to GLPG1690 in IPF: ISABELA2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.